Computer Aided Diagnosis of Multiple Eye Fundus Diseases From Color Fundus Photograph

NCT ID: NCT04723160

Last Updated: 2021-12-30

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

748 participants

Study Classification

OBSERVATIONAL

Study Start Date

2020-08-10

Study Completion Date

2021-05-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Blindness can be caused by many ocular diseases, such as diabetic retinopathy, retinal vein occlusion, age-related macular degeneration, pathologic myopia and glaucoma. Without timely diagnosis and adequate medical intervention, the visual impairment can become a great burden on individuals as well as the society. It is estimated that China has 110 million patients under the attack of diabetes, 180 million patients with hypertension, 120 million patients suffering from high myopia and 200 million people over 60 years old, which suggest a huge population at the risk of blindness. Despite of this crisis in public health, our society has no more than 3,000 ophthalmologists majoring in fundus oculi disease currently. As most of them assembling in metropolitan cities, health system in this field is frail in primary hospitals. Owing to this unreasonable distribution of medical resources, providing medical service to hundreds of millions of potential patients threatened with blindness is almost impossible.

To solve this problem, this software (MCS) was developed as a computer-aided diagnosis to help junior ophthalmologists to detect 13 major retina diseases from color fundus photographs. This study has been designed to validate the safety and efficiency of this device.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

As a prospective clinical trial, This study enjoys multicentric, blind film reading, self-control and superiority test design. In total, 1,500 retinal fundus images from 750 individuals in need of fundus examination (one image for every single eye) were selected. Then a test group, along with a control group was set up in our study. For the test group, ophthalmologists read images with the aid of the assistant software(MCS). In contrast, the same work in the control group was finished by ophthalmologists independently. Meanwhile, the gold standard were obtained from the cooperation of senior ophthalmologists. Diagnoses of both groups were compared with those of the gold standard, thus the investigators could evaluated the safety and effectiveness of this assistant software in diagnosis.

The primary endpoint of this study is the superiority of the consistency rate of the test group. A diagnosis for an image is consistent if it gives the same negative result as the reference standard, or reveals any one condition indicated by the reference standard. The consistency rate is the rate of consistent diagnoses for all the involved images. One control group is designed, where each doctor reads and diagnoses, and give at most 3 possible conditions for each image. In the test group, doctors do the same thing with the help of this software. The investigators in the test group and control group are the same and they are chosen from ophthalmologists with 1\~3 years experience. The reference standard of each fundus image is collaboratively given by retinal specialists/fellows from 5 centers. The investigator of XieHe center is the arbitrator if full consensus cannot be reached for any image during the building of reference standard.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Diabetic Retinopathy Retinal Vein Occlusion Retinal Artery Occlusion Central Serous Chorioretinopathy Pathologic Myopia Retinitis Pigmentosa Epiretinal Membrane Macular Holes Nonexudative Age-related Macular Degeneration Exudative Age Related Macular Degeneration Suspect Glaucoma Optic Atrophy Retinal Detachment

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

multiple eye fundus diseases

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Test Group

ophthalmologists read images applying the assistant software

Software assisted imaging diagnosis

Intervention Type DIAGNOSTIC_TEST

In the test group, diagnoses are given with the help of the software.

Control Group

ophthalmologists read images independently

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Software assisted imaging diagnosis

In the test group, diagnoses are given with the help of the software.

Intervention Type DIAGNOSTIC_TEST

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age between 18 and 75.
* Anyone need to take fundus photograph in clinical.
* Understand the study and volunteer to sign the informed consent.
* For fundus images of participants, the optic disc, fovea, the upper and lower vessel bow should be included in the fundus field.

Exclusion Criteria

* Participants has any eye that cannot take fundus photos.
* Participants have joined or is participating in other clinical trial within one month.
* Participants who have any other issue that cannot be enrolled.
* Participants with cloudy refractive media that cannot take fundus photos or get clouding fundus photos.
* Participants with low quality fundus photos like incompetent vision field, overexposed/underexposed, out of focus, too many shadow or dirties and so on.
Minimum Eligible Age

18 Years

Maximum Eligible Age

75 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Peking University First Hospital

OTHER

Sponsor Role collaborator

Beijing Municipal Science & Technology Commission

OTHER

Sponsor Role collaborator

Visionary Intelligence Ltd.

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

You xin Chen, PHD

Role: STUDY_CHAIR

Peking Union Medical College

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Peking Union Medical College Hospital, Chinese Academy of Medical Sciences

Beijing, Beijing Municipality, China

Site Status

The Second Hospital of Hebei Medical University

Shijiazhuang, Hebei, China

Site Status

West China Hospital of Sichuan University

Chengdu, Sichuan, China

Site Status

Tianjin Medical University Eye Hospital

Tianjin, Tianjin Municipality, China

Site Status

Eye Hospital, WMU Zhejiang Eye Hospital

Wenzhou, Zhejiang, China

Site Status

Countries

Review the countries where the study has at least one active or historical site.

China

References

Explore related publications, articles, or registry entries linked to this study.

Li B, Chen H, Yu W, Zhang M, Lu F, Ma J, Hao Y, Li X, Hu B, Shen L, Mao J, He X, Wang H, Ding D, Li X, Chen Y. The performance of a deep learning system in assisting junior ophthalmologists in diagnosing 13 major fundus diseases: a prospective multi-center clinical trial. NPJ Digit Med. 2024 Jan 11;7(1):8. doi: 10.1038/s41746-023-00991-9.

Reference Type DERIVED
PMID: 38212607 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

BLG-20200101

Identifier Type: -

Identifier Source: org_study_id